GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Lifesciences | Pharmaceuticals

GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Market by Product, Application, End-user, and Geography | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The detailed analysis of the global pharmaceutical continuous manufacturing market suggests that based on revenue, the market is likely to surge at a CAGR of 10.35% during the forecast years 2021-2028. Further, the market acquired $369.1 million in 2020, and is expected to attain revenue worth $937.7 million by 2028.


Report scope can be customized per your requirements. Request For Customization

The continuous pharmaceutical manufacturing systems provide significant advantages, such as reduced production fluctuation, improved yields, low cost of operation and equipment, thereby fueling the studied market’s growth.

Furthermore, continuous manufacturing is an innovative manufacturing method, accomplished by employing end-to-end integration of manufacturing subprocesses with a significant control strategies level. Moreover, it reduces energy needs, is more time-efficient, and helps increase productivity, while minimizing the overall waste. Hence, these factors are anticipated to offer the global pharmaceutical continuous manufacturing market with lucrative opportunities over the considered phase.

The study aims to get an overview of the pharmaceutical continuous manufacturing market in terms of various factors. Within this report, the key insight and the market description regarding the market have been discussed. Also, Porter’s five forces model; the impact of COVID-19; legal, policy, & regulatory framework; vendor scorecard; and market attractiveness index, have been studied in detail.

The rise in initiatives by regulatory authorities for the adoption of continuous manufacturing, growing acceptance of PCM systems, and surging healthcare expenditures, are factors that are driving the global market’s development. Additionally, the rising opportunities in the untapped emerging economies and an increase in large molecules and biologics manufacturing, are key opportunities that can be leveraged by the market to reach the projected growth.

However, the major restraints, such as lack of demand for pharmaceutical continuous manufacturing systems in underdeveloped countries and growing customer expectations for better medicines, are obstructing the overall growth of the pharmaceutical continuous manufacturing market.



Key geographies covered in the pharmaceutical continuous manufacturing market are:

•           NorthAmerica: United States and Canada

•           Europe: Germany, United Kingdom, Spain, Italy, Russia, France, and Rest of Europe

•           Asia-Pacific: Japan, China, India, South Korea, ASEAN countries, New Zealand & Australia, and Rest of Asia-Pacific

•           LatinAmerica: Mexico, Brazil, and Rest of Latin America

•           MiddleEast and Africa: Turkey, Saudi Arabia, South Africa, United Arab Emirates, and Rest of Middle East & Africa

The segmentation analysis of the pharmaceutical continuous manufacturing market includes:

•           Market by Product:

           o          Integrated Continuous System

           o          Semi-Continuous System

           o          Control & Software

•           Market by Application:

           o          Final Drug Product Manufacturing

           o          API Manufacturing

•           Market by End-user:

           o          Pharmaceutical Companies

           o          Contract Manufacturing Companies

           o          Other End-users

 

The renowned companies profiled in the pharmaceutical continuous manufacturing market is Eli Lilly & Company, Munson Machinery Company, Siemens Healthineers, Syntegon, GEA Group AG, Coperion GmbH, Hosokawa Micron Corporation, Korsch AG, LB Bohle Maschinen + Verfahren GmbH, Gebruder Lodige Maschinenbau GmbH, Pfizer Inc, Thermofisher Scientific Inc, and Glatt GmbH.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1.   THREAT OF NEW ENTRANTS

2.1.2.   THREAT OF SUBSTITUTE PRODUCTS

2.1.3.   BARGAINING POWER OF BUYERS

2.1.4.   BARGAINING POWER OF SUPPLIERS

2.1.5.   COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

2.3. LEGAL, POLICY, & REGULATORY FRAMEWORK

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY INSIGHTS

2.7. MARKET DRIVERS

2.7.1.   RISE IN INITIATIVES BY REGULATORY AUTHORITIES FOR THE ADOPTION OF CONTINUOUS MANUFACTURING

2.7.2.   SURGING ACCEPTANCE OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS

2.7.3.   RISING HEALTHCARE EXPENDITURE

2.8. MARKET RESTRAINTS

2.8.1.   LACK OF DEMAND FOR PCM SYSTEMS IN UNDERDEVELOPED ECONOMIES

2.8.2.   RISING CUSTOMER EXPECTATIONS FOR BETTER MEDICINES

2.9. MARKET OPPORTUNITIES

2.9.1.   INCREASING OPPORTUNITIES IN THE UNTAPPED EMERGING ECONOMIES

2.9.2.   SURGE IN THE MANUFACTURING OF LARGE MOLECULES AND BIOLOGICS

3.    GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY PRODUCT

3.1. INTEGRATED CONTINUOUS SYSTEM

3.2. SEMI-CONTINUOUS SYSTEM

3.3. CONTROL & SOFTWARE

4.    GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY APPLICATION

4.1. FINAL DRUG PRODUCT MANUFACTURING

4.2. API MANUFACTURING

5.    GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY END-USER

5.1. PHARMACEUTICAL COMPANIES

5.2. CONTRACT MANUFACTURING ORGANIZATIONS

5.3. OTHER END-USERS

6.    GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1.   MARKET BY PRODUCT

6.1.2.   MARKET BY APPLICATION

6.1.3.   MARKET BY END-USER

6.1.4.   COUNTRY ANALYSIS

6.1.4.1. UNITED STATES

6.1.4.2. CANADA

6.2. EUROPE

6.2.1.   MARKET BY PRODUCT

6.2.2.   MARKET BY APPLICATION

6.2.3.   MARKET BY END-USER

6.2.4.   COUNTRY ANALYSIS

6.2.4.1. GERMANY

6.2.4.2. FRANCE

6.2.4.3. UNITED KINGDOM

6.2.4.4. ITALY

6.2.4.5. RUSSIA

6.2.4.6. SPAIN

6.2.4.7. REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1.   MARKET BY PRODUCT

6.3.2.   MARKET BY APPLICATION

6.3.3.   MARKET BY END-USER

6.3.4.   COUNTRY ANALYSIS

6.3.4.1. CHINA

6.3.4.2. INDIA

6.3.4.3. JAPAN

6.3.4.4. AUSTRALIA & NEW ZEALAND

6.3.4.5. SOUTH KOREA

6.3.4.6. ASEAN COUNTRIES

6.3.4.7. REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1.   MARKET BY PRODUCT

6.4.2.   MARKET BY APPLICATION

6.4.3.   MARKET BY END-USER

6.4.4.   COUNTRY ANALYSIS

6.4.4.1. MEXICO

6.4.4.2. BRAZIL

6.4.4.3. REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1.   MARKET BY PRODUCT

6.5.2.   MARKET BY APPLICATION

6.5.3.   MARKET BY END-USER

6.5.4.   COUNTRY ANALYSIS

6.5.4.1. SAUDI ARABIA

6.5.4.2. UNITED ARAB EMIRATES

6.5.4.3. TURKEY

6.5.4.4. SOUTH AFRICA

6.5.4.5. REST OF MIDDLE EAST & AFRICA

7.    COMPANY PROFILE

7.1. HOSOKAWA MICRON CORPORATION

7.2. GEA GROUP AG

7.3. LB BOHLE MASCHINEN + VERFAHREN GMBH

7.4. THERMOFISHER SCIENTIFIC INC

7.5. SIEMENS HEALTHINEERS

7.6. ELI LILLY & COMPANY

7.7. PFIZER INC

7.8. GLATT GMBH

7.9. SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)

7.10. GEBRUDER LODIGE MASCHINENBAU GMBH

7.11. KORSCH AG

7.12. COPERION GMBH

7.13. MUNSON MACHINERY COMPANY

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1:       GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY REGION, 2021-2028 (IN $ MILLION)

TABLE 2:       PROJECTED NATIONAL HEALTHCARE EXPENDITURE 2021-2028 (IN $ BILLION)

TABLE 3:       GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 4:       GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 5:       GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 6:       GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY REGION, 2021-2028 (IN $ MILLION)

TABLE 7:       NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 8:       NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 9:       NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 10:     NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 11:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 12:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 13:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 14:     EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 15:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 16:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 17:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 18:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 19:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 20:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 21:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 22:     LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 23:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 24:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 25:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 26:     MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 3:     GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 4:     GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 5:     GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 6:     GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 7:     GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 8:     GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9:     GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 10:  UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2020-2028 (IN $ MILLION)

FIGURE 11:  CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2020-2028 (IN $ MILLION)

FIGURE 12:  GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 13:  FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 14:  UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 15:  ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 16:  RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 17:  SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 18:  REST OF EUROPE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 19:  CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 20:  INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 21:  JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 22:  AUSTRALIA & NEW ZEALAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 23:  SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 24:  ASEAN COUNTRIES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 25:  REST OF ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 26:  MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 27:  BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 28:  REST OF LATIN AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 29:  SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 30:  UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 31:  TURKEY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 32:  SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 33:  REST OF MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;